Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Authors
Ugurel, SRohmel, J
Ascierto, PA
Becker, JC
Flaherty, KC
Grob, JJ
Hauschild, A
Larkin, J
Livingstone, E
Long, GV
Lorigan, Paul C
McArthur, GA
Ribas, A
Robert, C
Zimmer, L
Schadendorf, D
Garbe, C
Affiliation
Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, GermanyIssue Date
2020
Metadata
Show full item recordCitation
Ugurel S, Rohmel J, Ascierto PA, Becker JC, Flaherty KT, Grob JJ, et al. Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019. Eur J Cancer. 2020;130:126-38.Journal
European Journal of CancerDOI
10.1016/j.ejca.2020.02.021PubMed ID
32179447Additional Links
https://dx.doi.org/10.1016/j.ejca.2020.02.021Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2020.02.021
Scopus Count
Collections
Related articles
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.
- Authors: Ugurel S, Röhmel J, Ascierto PA, Flaherty KT, Grob JJ, Hauschild A, Larkin J, Long GV, Lorigan P, McArthur GA, Ribas A, Robert C, Schadendorf D, Garbe C
- Issue date: 2017 Sep
- Survival of patients with advanced metastatic melanoma: The impact of novel therapies.
- Authors: Ugurel S, Röhmel J, Ascierto PA, Flaherty KT, Grob JJ, Hauschild A, Larkin J, Long GV, Lorigan P, McArthur GA, Ribas A, Robert C, Schadendorf D, Garbe C
- Issue date: 2016 Jan
- First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
- Authors: Schilling B, Martens A, Geukes Foppen MH, Gebhardt C, Hassel JC, Rozeman EA, Gesierich A, Gutzmer R, Kähler KC, Livingstone E, Diamantopoulos PT, Gogas H, Madonna G, Ascierto PA, Goldinger SM, Mangana J, Garbe C, Schadendorf D, Blank C, Weide B
- Issue date: 2019 May
- Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
- Authors: Devji T, Levine O, Neupane B, Beyene J, Xie F
- Issue date: 2017 Mar 1
- Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
- Authors: Franklin C, Mohr P, Bluhm L, Meier F, Garzarolli M, Weichenthal M, Kähler K, Grimmelmann I, Gutzmer R, Utikal J, Terheyden P, Herbst R, Haferkamp S, Pfoehler C, Forschner A, Leiter U, Ziller F, Meiss F, Ulrich J, Kreuter A, Gebhardt C, Welzel J, Schilling B, Kaatz M, Scharfetter-Kochanek K, Dippel E, Nashan D, Sachse M, Weishaupt C, Löffler H, Gambichler T, Loquai C, Heinzerling L, Grabbe S, Debus D, Schley G, Hassel JC, Weyandt G, Trommer M, Lodde G, Placke JM, Zimmer L, Livingstone E, Becker JC, Horn S, Schadendorf D, Ugurel S
- Issue date: 2023 Apr